Novavax (NVAX) Shares Outstanding (Diluted Average) (2019 - 2026)

Novavax's Shares Outstanding (Diluted Average) history runs 8 years deep, the most recent figure standing at $163.3 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) fell 8.08% year-over-year to $163.3 million; the TTM figure through Mar 2026 stood at $163.3 million (down 8.08% YoY), while the FY2025 annual figure was $173.1 million, up 13.74% from the prior year.
• Shares Outstanding (Diluted Average) was $163.3 million for Q1 2026 at Novavax, down from $173.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $177.6 million in Q1 2025 to a low of $77.6 million in Q3 2022.
• Historically, Shares Outstanding (Diluted Average) has averaged $125.5 million across 5 years, with a median of $139.9 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Diluted Average) soared 65.34% in 2024, then decreased 8.08% in 2026.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $78.2 million in 2022, then advanced by 28.89% to $100.8 million in 2023, then jumped by 51.03% to $152.2 million in 2024, then climbed by 13.74% to $173.1 million in 2025, then slipped by 5.68% to $163.3 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $163.3 million (Q1 2026), $173.1 million (Q4 2025), and $162.4 million (Q3 2025), per Business Quant data.